9 Matching Annotations
  1. May 2024
  2. aacrjournals.org aacrjournals.org
    Niraparib plus Dostarlimab in Pleural Mesothelioma or Non-Small Cell Lung Cancer harboring HRR mutations: interim results of the UNITO-001 phase 2 prospective trial
    1
    1. scibot 23 May 2024
      RRID:AB_2833074

      DOI: 10.1158/1078-0432.CCR-23-2431

      Resource: (Agilent Cat# GE00621-2, RRID:AB_2833074)

      Curator: @abever99

      SciCrunch record: RRID:AB_2833074

      What is this?
      RRID:AB_2833074 DOI:10.1158/1078-0432.CCR-23-2431
    Visit annotations in context

    Tags

    Annotators

    URL

    aacrjournals.org/clincancerres/article/30/5/959/734303/Niraparib-plus-Dostarlimab-in-Pleural-Mesothelioma
  3. Feb 2024
  4. 52.53.155.43 52.53.155.43
    delete-html.html
    2
    1. scibot 29 Feb 2024
      RRID:AB_2833074

      DOI: 10.1158/1078-0432.ccr-23-2431

      Resource: (Agilent Cat# GE00621-2, RRID:AB_2833074)

      Curator: @scibot

      SciCrunch record: RRID:AB_2833074

      What is this?
      RRID:AB_2833074
    2. scibot 29 Feb 2024
      RRID:AB_2833074

      DOI: 10.1158/1078-0432.ccr-23-2431

      Resource: (Agilent Cat# GE00621-2, RRID:AB_2833074)

      Curator: @scibot

      SciCrunch record: RRID:AB_2833074

      What is this?
      RRID:AB_2833074
    Visit annotations in context

    Tags

    Annotators

    URL

    52.53.155.43/cf598364e2561e3de494d0af6acdee45e74e56b3/delete-html.html
  5. Oct 2023
  6. www.sciencedirect.com www.sciencedirect.com
    Real-world efficacy and safety of low-dose pembrolizumab in patients with advanced and refractory gynecologic cancers
    1
    1. scibot 22 Oct 2023
      RRID:AB_2833074

      DOI: 10.1016/j.jfma.2023.09.020

      Resource: (Agilent Cat# GE00621-2, RRID:AB_2833074)

      Curator: @scibot

      SciCrunch record: RRID:AB_2833074

      What is this?
      RRID:AB_2833074
    Visit annotations in context

    Tags

    Annotators

    URL

    sciencedirect.com/science/article/pii/S0929664623003996
  7. Jun 2023
  8. www.ncbi.nlm.nih.gov www.ncbi.nlm.nih.gov
    A Phase II Trial of Guadecitabine plus Atezolizumab in Metastatic Urothelial Carcinoma Progressing after Initial Immune Checkpoint Inhibitor Therapy
    1
    1. scibot 03 Jun 2023
      RRID:AB_2833074

      DOI: 10.1158/1078-0432.CCR-22-3642

      Resource: (Agilent Cat# GE00621-2, RRID:AB_2833074)

      Curator: @scibot

      SciCrunch record: RRID:AB_2833074

      What is this?
      RRID:AB_2833074
    Visit annotations in context

    Tags

    Annotators

    URL

    ncbi.nlm.nih.gov/pmc/articles/PMC10233355/
  9. Jan 2023
  10. www.ncbi.nlm.nih.gov www.ncbi.nlm.nih.gov
    Case report: Durable response after pembrolizumab in combination with radiation - induced abscopal effect in platinum - refractory metastatic endometrial clear cell carcinoma
    1
    1. scibot 06 Jan 2023
      AB_2833074

      DOI: 10.3389/fimmu.2022.1079253

      Resource: (Agilent Cat# GE00621-2, RRID:AB_2833074)

      Curator: @scibot

      SciCrunch record: RRID:AB_2833074

      What is this?
      RRID:AB_2833074
    Visit annotations in context

    Tags

    Annotators

    URL

    ncbi.nlm.nih.gov/pmc/articles/PMC9797856/
  11. Oct 2022
  12. www.ncbi.nlm.nih.gov www.ncbi.nlm.nih.gov
    Tumoral PD-L1 does not impact time to treatment discontinuation in EGFR mutated non-small cell lung cancer patients treated with EGFR tyrosine kinase inhibitor—a Danish cohort study
    1
    1. scibot 14 Oct 2022
      RRID:AB_2833074

      DOI: 10.21037/tlcr-22-211

      Resource: (Agilent Cat# GE00621-2, RRID:AB_2833074)

      Curator: @scibot

      SciCrunch record: RRID:AB_2833074

      What is this?
      RRID:AB_2833074
    Visit annotations in context

    Tags

    Annotators

    URL

    ncbi.nlm.nih.gov/pmc/articles/PMC9554682/
  13. Sep 2022
  14. www.ncbi.nlm.nih.gov www.ncbi.nlm.nih.gov
    Correlation between PD-L1 expression and radiomic features in early-stage lung adenocarcinomas manifesting as ground-glass nodules
    1
    1. scibot 30 Sep 2022
      RRID:AB_2833074

      DOI: 10.3389/fonc.2022.986579

      Resource: (Agilent Cat# GE00621-2, RRID:AB_2833074)

      Curator: @scibot

      SciCrunch record: RRID:AB_2833074

      What is this?
      RRID:AB_2833074
    Visit annotations in context

    Tags

    Annotators

    URL

    ncbi.nlm.nih.gov/pmc/articles/PMC9513584/
  15. Feb 2022
  16. www.ncbi.nlm.nih.gov www.ncbi.nlm.nih.gov
    PD-L1 expression and patient outcomes in gastrointestinal neuroendocrine neoplasm: a meta-analysis
    1
    1. scibot 05 Feb 2022
      RRID:AB_2833074

      DOI: 10.21037/tcr-20-3482

      Resource: (Agilent Cat# GE00621-2, RRID:AB_2833074)

      Curator: @scibot

      SciCrunch record: RRID:AB_2833074

      What is this?
      RRID:AB_2833074
    Visit annotations in context

    Tags

    Annotators

    URL

    ncbi.nlm.nih.gov/pmc/articles/PMC8798646/